State of Wyoming’s 2seventy bio TSVT Stock Holding History

State of Wyoming’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-520	Closed	-$7K	–	1935
2022 Q2	$7K	Buy	+520	New	+$7.08K	﹤0.01%	1691

Other funds holding TSVT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

State of Wyoming's TSVT Position: Q3 2022 in Review

State of Wyoming sold out of 2seventy bio (TSVT) in Q3 2022, closing a stake of 520 shares — an estimated $7K sold.

State of Wyoming first reported a position in TSVT in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 133 funds tracked by Wall St. Rank hold TSVT as of Q3 2022.

State of Wyoming reported no remaining 2seventy bio position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 520 2seventy bio shares in Q3 2022, an estimated $7K.
State of Wyoming first reported a position in 2seventy bio in Q2 2022 and held it in 1 quarter.
State of Wyoming's 2seventy bio position peaked at $7K in Q2 2022.
133 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.